article Open AccessTop 1% cited
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
Cell Metabolism · 2020 · Vol. 31(6) · pp. 1068–1077.e3
Lihua Zhu✉(Renmin Hospital of Wuhan University)Zhi‐Gang She(Wuhan University)Xu Cheng(Wuhan University)Juan‐Juan Qin(Wuhan University)Xiao-Jing Zhang(Wuhan University)Jingjing Cai(Third Xiangya Hospital)Fang Lei(Wuhan University)Haitao Wang(Zhongnan Hospital of Wuhan University)Jing Xie(Renmin Hospital of Wuhan University)Wenxin Wang(Renmin Hospital of Wuhan University)Haomiao Li(Renmin Hospital of Wuhan University)Peng Zhang(Wuhan University)Xiaohui Song(Wuhan University)Xi Chen(Wuhan University)Mei Xiang(Huazhong University of Science and Technology)Chaozheng Zhang(Wuhan University)Liangjie Bai(Wuhan University)Xiang Da(Wuhan University)Ming-Ming Chen(Renmin Hospital of Wuhan University)Yanqiong Liu(Wuhan University)Youqin Yan(Wuhan No. 7 Hospital)Mingyu LiuWeiming Mao(Huanggang Central Hospital)Jinjing Zou(Wuhan University)Li Liu(Ezhou Central Hospital)Guohua ChenPengcheng Luo(Wuhan Third Hospital)Bing Xiao(Yancheng First People's Hospital)Changjiang Zhang(Wuhan University)Zixiong Zhang(The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture)Zhigang Lu(First People’s Hospital of Jingmen)Junhai Wang(First People’s Hospital of Jingmen)Haofeng Lu(First People's Hospital of Jingzhou)Xigang Xia(Jingzhou Central Hospital)Daihong Wang(Xianning Central Hospital)Xiaofeng Liao(Hubei University of Arts and Science)Gang Peng(Suizhou Central Hospital)Ping Ye(Central Hospital of Wuhan)Jun Yang(Yichang Central People's Hospital)Yufeng Yuan(Zhongnan Hospital of Wuhan University)Xiaodong Huang(Wuhan Third Hospital)Jiao Guo(Guangdong Pharmaceutical University)Bing-Hong Zhang(Renmin Hospital of Wuhan University)Hongliang Li(Wuhan University)
COVID-19 Clinical Research StudiesDiabetes and associated disordersDiabetes Management and ResearchGlycemicMedicineType 2 diabetesComorbidityInternal medicineHazard ratioDiabetes mellitusCoronavirus disease 2019 (COVID-19)Retrospective cohort studyPsychological intervention
MeSH terms
BetacoronavirusCOVID-19SARS-CoV-2AgedBlood GlucoseDiabetes Mellitus, Type 2Disease SusceptibilityFemaleHospitalizationHumansHyperglycemiaHypoglycemic AgentsLongitudinal StudiesMaleMiddle Aged
Funding
- National Natural Science Foundation of China
Citations
1,643
FWCI
37.01
field-weighted impact
References
42
Percentile
100%
vs. same field & year
Citations per year
Cited by
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Circulation · 2022 · 5,901 citations
References
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Nature Medicine · 2005 · 3,627 citations
Comparison of imputation methods for missing laboratory data in medicine
BMJ Open · 2013 · 494 citations
Sensitivity Analysis in Observational Research: Introducing the E-Value
Annals of Internal Medicine · 2017 · 5,350 citations
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
The Lancet · 2020 · 51,571 citations
A Novel Coronavirus from Patients with Pneumonia in China, 2019
New England Journal of Medicine · 2020 · 30,188 citations
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
The Lancet · 2020 · 22,618 citations
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
The Lancet · 2020 · 12,526 citations
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
JAMA · 2020 · 21,111 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.